[Form 4] EchoStar CORP Insider Trading Activity
Paul Gaske, identified as COO, HUGHES and a reporting person for EchoStar CORP (SATS), reported multiple transactions dated 09/12/2025. The Form 4 shows several dispositions of Class A common stock (codes S) at prices ranging from $75.63 to $78.32 and acquisitions recorded with code M at $14.04. Reported non-derivative activity includes sales of 750, 1,444, 2,964, 5,075 shares and acquisitions of 2,964 and 5,075 shares (as shown). Table II reports two employee stock option grants at an exercise price of $14.04 dated 09/12/2025: one for 2,964 options and one for 5,075, each exercisable on specified dates with expiration 04/01/2034. The filing includes vesting schedules: 40% of one option grant vested immediately with remaining vesting on April 1, 2025 and April 1, 2026; the other grant vests 25% per year from April 1, 2025 through April 1, 2028. The form is signed by Paul Gaske via attorney-in-fact on 09/16/2025.
- None.
- None.
Insights
TL;DR: Insider exercised and received employee stock options and sold portions of Class A shares on 09/12/2025; new option grants issued at $14.04.
The Form 4 documents mixed activity: multiple open-market sales of Class A common stock at prices between $75.63 and $78.32, and simultaneous acquisitions recorded at $14.04, consistent with issuance/exercise-related movements. Two employee stock option grants totaling 8,039 options were reported with an exercise price of $14.04 and expiration on 04/01/2034. Vesting schedules are specified, including a partial immediate vesting (40%) for one grant and multi-year vesting for both grants. For investors, this indicates management equity compensation activity but does not by itself imply changes to company operations or financials.
TL;DR: Report shows standard insider compensation and sales; option grants include clear vesting timelines and a long expiration.
The filing is a routine Section 16 disclosure showing that an officer engaged in both sales and option-related acquisitions. The two option awards have explicit vesting schedules and a common expiration date of 04/01/2034. Sales were executed at market prices listed on the form. The filing is properly executed and signed by an attorney-in-fact, and includes an explanation of vesting mechanics. No governance red flags such as unexplained transfers or blackout-period issues are evident within the disclosed text.